Proactive Investors
12 Oct 2026, 23:27 UTC · 1h ago
Lumos Diagnostics appoints Tenmile Ventures representative to board as US commercialisation advances
Impact · against what's priced in
The updates for LDX and ECOB are minor and largely operational. LDX's board change increases shareholder oversight of US commercialization, while ECOB's AI production line remains on track as expected.
- LDX+0.20
No priced-in read yet
- In context





